Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10954268
Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
granted -
US 10954248
Bryoid compositions, methods of making and use thereof
granted -
US 10954237
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10954228
1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10954217
Sigma receptor binders
granted -
US 10953113
Imaging agents and methods of use
granted -
US 10953187
Configurable oxygen concentrator and related method
granted -
US 10953083
Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
granted -
US 10953085
Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems
granted -
US 10953095
Lipid compositions
granted -
US 10953077
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10953098
Chemical structures for localized delivery of therapeutic agents
granted -
US 10953046
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10953031
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 10953003
Methods for treating cancer
granted -
US 10953018
Emulsion formulations of aprepitant
granted -
US 10952993
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
granted -
US 10952980
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted -
US 10952970
Use of vitelline protein B as a microencapsulating additive
granted -
US 10952997
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10953000
Combination of pimavanserin and cytochrome P450 modulators
granted -
US 10954192
Pyrrolomycins and methods of using the same
granted -
US 10953028
Method of treating heterotopic ossification
granted -
WO 2021048135
COMBINAISONS PHARMACEUTIQUES COMPRENANT UN FURAZANOBENZIMIDAZOLE ET UN AGONISTE DE CD40 POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.